Jyong Bio (MENS): Kapitalisasi marang volume dodolan
A critical liquidity shortage and dependence on loans predetermine a negative trend, as confirmed by the P/S levels on the Jyong Biotech Ltd (MENS) chart available on GURU.Markets, where the current metric equals . Trade wars between Beijing and Washington further complicate the situation by creating export barriers. Additionally, the global market fragmentation disrupts raw material supply chains and hinders the conduct of international clinical trials.
Rincian analitis perusahaan Jyong Bio (MENS)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Utang marang Ekuitas Jyong Biotech Ltd|MENS - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Jyong Biotech|MENS - Gunggung utang perusahaan|Rasio utang marang aset resik Jyong Bio|MENS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Jyong Biotech|Koefisien jangkoan perantara jyongbio.com
- data bathi lan kelipatan valuasi:
MENS - Bathi resik perusahaan|Bathi resik sing dikarepake Jyong Biotech Ltd|MENS - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Jyong Biotech Corp|MENS - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Jyong Bio|MENS - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Jyong Biotech|MENS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan jyongbio.com|MENS - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Jyong Biotech Ltd
- data total pendapatan lan volume dodolan:
Ringkesan analitik perusahaan:Jyong Biotech, MENS
The P/S multiple compares the market capitalization of Jyong Biotech Ltd (MENS) to its revenue, allowing for the valuation of each unit of sales within fundamental analysis. The stability of biopharmaceutical supply chains minimizes operational risks; therefore, the P/S multiple trend serves as an accurate indicator of market confidence in the efficiency of this logistics model and the justification of the current business valuation.
Perusahaan pesaing
HLN (Haleon) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue Inc KVUE|Verona Pharma Corp - Rasio rega marang pendapatan|ligand.com - Multiplikator P/S|amneal.com (AMRX) - Kapitalisasi marang pendapatan|Perrigo (PRGO) - Rasio rega marang pendapatan|ALVO (Alvotech S.A.) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan LQDA|Multiplikator P/S Galapagos Corp|Rasio rega marang pendapatan ANI Pharma (ANIP)|Multiplikator P/S MannKind Corporation (MNKD)|Rasio rega marang pendapatan Amphastar Pharmaceuticals Inc AMPH|Multiplikator P/S Pacira PCRX|ARS Pharmaceuticals Inc - Multiplikator P/S|TBPH - Multiplikator P/S|AQST (Aquestive Therapeutics) - Kapitalisasi marang pendapatan|scPharmaceuticals, Inc. (SCPH) - Multiplikator P/S|Kapitalisasi marang pendapatan TECX|Multiplikator P/S Tonix Pharma|Kapitalisasi marang pendapatan SXTC (SXT Pharmaceuticals)|EPRX: Rasio rega marang dodolan|BioHarvest Sciences - Kapitalisasi marang pendapatan|EXOZ: Rasio kapitalisasi marang pendapatan|ORMP - Rasio rega marang pendapatan|ENTX: Rasio rega marang pendapatan|HYFT: Multiplikator P/S|Kapitalisasi marang pendapatan ABVC BioPharma Inc|CPIX (Cumberland Corp) - Multiplikator P/S|Multiplikator P/S quantumbiopharma.com|Multiplikator P/S FGEN|Kapitalisasi marang pendapatan Telomir Pharmaceuticals, Inc. TELO|Multiplikator P/S RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Rasio rega marang dodolan|RLYB: Kapitalisasi marang pendapatan|lexariabioscience.com (LEXX) - Kapitalisasi marang pendapatan|Pulmatrix Inc (PULM) - Rasio rega marang pendapatan|PTHL: Kapitalisasi marang volume dodolan|APM (Aptorum Group Ltd) - Multiplikator P/S|Lyra Therapeutics Inc (LYRA) - Koefisien rega marang pendapatan|Multiplikator P/S IBO|Kapitalisasi marang volume dodolan TNFA|cbdMD, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PRFX|Altamira Therapeutics Ltd. - Multiplikator P/S|LIPO: Rasio rega marang pendapatan|OPTN: Multiplikator P/S|Rasio rega marang dodolan PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - Multiplikator P/S|PTPI (Petros Pharmaceuticals Inc) - Kapitalisasi marang volume dodolan|Multiplikator P/S QLI|SLRN - Rega marang dodolan|Multiplikator P/S TFFP (TFF Pharmaceuticals, Inc)
